Literature DB >> 17594100

Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer.

M H Wink1, J J M C H de la Rosette, C A Grimbergen, H Wijkstra.   

Abstract

The diagnosis of prostate cancer is based on histology. Prostate biopsies are obtained based on the triad of prostate specific antigen (PSA), digital rectal examination (DRE) and transrectal ultrasound. Because prostate biopsies still have a large percentage of negative outcomes, patient selection and biopsy direction need improvement. This paper describes the recent improvements in prostate cancer imaging, especially contrast-enhanced transrectal ultrasound.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17594100     DOI： 10.1007/s00345-007-0189-0

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


  52 in total

1.  Prostate cancer: contrast-enhanced us for detection.

Authors:  E J Halpern; M Rosenberg; L G Gomella
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

2.  Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma.

Authors:  Robert J Eckersley; J P Michiel Sedelaar; Martin J K Blomley; Hessel Wijkstra; Nandita M deSouza; David O Cosgrove; Jean J M C H de la Rosette
Journal:  Prostate       Date:  2002-06-01       Impact factor: 4.104

3.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

4.  Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers.

Authors:  E Kuligowska; M A Barish; H M Fenlon; M Blake
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

5.  Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam).

Authors:  P M Beemsterboer; R Kranse; H J de Koning; J D Habbema; F H Schröder
Journal:  Int J Cancer       Date:  1999-08-20       Impact factor: 7.396

6.  Contrast-enhanced ultrasound of the kidneys.

Authors:  Anders Nilsson
Journal:  Eur Radiol       Date:  2004-10       Impact factor: 5.315

Review 7.  Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.

Authors:  Andrew W Roddam; Michael J Duffy; Freddie C Hamdy; Anthony Milford Ward; Julietta Patnick; Christopher P Price; Janet Rimmer; Cathie Sturgeon; Peter White; Naomi E Allen
Journal:  Eur Urol       Date:  2005-09       Impact factor: 20.096

8.  [Computerized supported transrectal ultrasound (C-TRUS) in the diagnosis of prostate cancer].

Authors:  T Loch
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

9.  Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine.

Authors:  Gregory E R Weller; Michael K K Wong; Ruth A Modzelewski; Erxiong Lu; Alexander L Klibanov; William R Wagner; Flordeliza S Villanueva
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

10.  Continuing trends in pathological stage migration in radical prostatectomy specimens.

Authors:  Ithaar H Derweesh; Patrick A Kupelian; Craig Zippe; Howard S Levin; Jennifer Brainard; Cristina Magi-Galluzzi; Jonathan Myles; Alwyn M Reuther; Eric A Klein
Journal:  Urol Oncol       Date:  2004 Jul-Aug       Impact factor: 3.498
View more
  1 in total

1.  Optoacoustic imaging of the prostate: development toward image-guided biopsy.

Authors:  Mohammad A Yaseen; Sergey A Ermilov; Hans-Peter Brecht; Richard Su; André Conjusteau; Matthew Fronheiser; Brent A Bell; Massoud Motamedi; Alexander A Oraevsky
Journal:  J Biomed Opt       Date:  2010 Mar-Apr       Impact factor: 3.170
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.